SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children
Joosse, I R, Wirtz, V J, van Mourik, A T, Wagner, B A, Mantel-Teeuwisse, A K, Suleman, F, van den Ham, H A
Published in BMC health services research (03.06.2023)
Published in BMC health services research (03.06.2023)
Get full text
Journal Article
Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
Petro, E, Perumal-Pillay, V, Mantel-Teeuwisse, A K, van den Ham, H A, Suleman, F
Published in Journal of pharmaceutical policy and practice (2024)
Published in Journal of pharmaceutical policy and practice (2024)
Get full text
Journal Article
The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non‐valvular atrial fibrillation
VAN DEN HAM, H. A., KLUNGEL, O. H., LEUFKENS, H. G. M., VAN STAA, T. P.
Published in Journal of thrombosis and haemostasis (01.01.2013)
Published in Journal of thrombosis and haemostasis (01.01.2013)
Get full text
Journal Article
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study
Ibáñez, Luisa, Sabaté, Mònica, Vidal, Xavier, Ballarin, Elena, Rottenkolber, Marietta, Schmiedl, Sven, Heeke, Andreas, Huerta, Consuelo, Martin Merino, Elisa, Montero, Dolores, Leon‐Muñoz, Luz María, Gasse, Christiane, Moore, Nicholas, Droz, Cécile, Lassalle, Régis, Aakjær, Mia, Andersen, Morten, De Bruin, Marie Louise, Groenwold, Rolf, Ham, Hendrika A., Souverein, Patrick, Klungel, Olaf, Gardarsdottir, Helga
Published in British journal of clinical pharmacology (01.11.2019)
Published in British journal of clinical pharmacology (01.11.2019)
Get full text
Journal Article
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study
Rottenkolber, Marietta, Schmiedl, Sven, Ibánez, Luisa, Sabaté, Mònica, Ballarín, Elena, Vidal, Xavier, Leon‐Muñoz, Luz María, Huerta, Consuelo, Martin Merino, Elisa, Montero, Dolores, Gasse, Christiane, Andersen, Morten, Aakjær, Mia, De Bruin, Marie Louise, Gerlach, Roman, Tauscher, Martin, Souverein, Patrick C., Ham, Rianne, Klungel, Olaf, Gardarsdottir, Helga
Published in Basic & clinical pharmacology & toxicology (01.03.2021)
Published in Basic & clinical pharmacology & toxicology (01.03.2021)
Get full text
Journal Article
Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project
Klungel, Olaf H., Kurz, Xavier, de Groot, Mark C. H., Schlienger, Raymond G., Tcherny-Lessenot, Stephanie, Grimaldi, Lamiae, Ibáñez, Luisa, Groenwold, Rolf H. H., Reynolds, Robert F.
Published in Pharmacoepidemiology and drug safety (01.03.2016)
Published in Pharmacoepidemiology and drug safety (01.03.2016)
Get full text
Journal Article
The IMI PROTECT project: purpose, organizational structure, and procedures
Reynolds, Robert F., Kurz, Xavier, de Groot, Mark C.H., Schlienger, Raymond G., Grimaldi-Bensouda, Lamiae, Tcherny-Lessenot, Stephanie, Klungel, Olaf H.
Published in Pharmacoepidemiology and drug safety (01.03.2016)
Published in Pharmacoepidemiology and drug safety (01.03.2016)
Get full text
Journal Article